ArchiMed is an independent investment firm specializing in the healthcare industry. It is a strategic and financial partner to European and North American companies operating in the Biopharma, Medtech, Diagnostics, Life Sciences, Healthcare IT, Consumer Health, Public Safety, and Care Services sectors.

ArchiMed’s international team combines investment, medical, technological, and operational experience. It works alongside management teams to accelerate their business growth, through internationalization, product and service range expansion as well as capacity extension, both organically and through acquisitions. Over the last 20 years, ArchiMed’s leadership team directly managed and invested in over 40 small, medium and large size healthcare companies throughout the world, with a combined value above five billion euros.

ArchiMed’s investment capacity currently exceeds one billion euros and potentially twice this amount when including its strategic investment partners.